OFFICIAL: EU AGENCY TO CONFIRM ASTRAZENECA BLOOD CLOT LINK

A top official at the European Medicines Agency says there’s a causal link between Astrazeneca’s coronavirus vaccine and rare blood clots, but that it’s unclear what the connection is and that the benefits of taking the shot still outweigh the risks of getting COVID-19.

Marco Cavaleri, head of health threats and vaccine strategy at the Amsterdam-based agency, told Rome’s Il Messaggero newspaper that the European Union’s medicines regulator is preparing to make a more definitive statement on the topic this week.